The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 28051871 |
100 |
Modulating Mineralocorticoid Receptor with Non-steroidal Antagonists. New Opportunities for the Development of Potent and Selective Ligands without Off-Target Side Effects. |
Instituto De Qu£Mica M£Dica (Iqm-Csic) |
| 22866979 |
19 |
Mineralocorticoid receptor antagonists for the treatment of hypertension and diabetic nephropathy. |
Pfizer |
| 21944856 |
51 |
Tetrahydroquinolines as a novel series of nonsteroidal selective androgen receptor modulators: structural requirements for better physicochemical and biological properties. |
Kaken Pharmaceutical |
| 21349712 |
15 |
Design and synthesis of tricyclic tetrahydroquinolines as a new series of nonsteroidal selective androgen receptor modulators (SARMs). |
Kaken Pharmaceutical |
| 21247762 |
13 |
Synthesis, modification, and evaluation of (R)-de-O-methyllasiodiplodin and analogs as nonsteroidal antagonists of mineralocorticoid receptor. |
Chinese Academy Of Sciences |
| 15911283 |
62 |
Novel ketal ligands for the glucocorticoid receptor: in vitro and in vivo activity. |
Merck Research Laboratories |
| 10908357 |
9 |
Recognition of a cognate RNA aptamer by neomycin B: quantitative evaluation of hydrogen bonding and electrostatic interactions. |
The Ohio State University |
Search and Browse
